Literature DB >> 6828803

Beta-blockade in the hyperventilation syndrome. A retrospective assessment of symptoms and complaints.

H Folgering, H Rutten, Y Roumen.   

Abstract

The effect of beta-adrenergic blockade on ventilatory parameters and on subjective complaints was studied in 73 patients suffering from hyperventilation syndrome. The beta-blockade made the PA,CO2 increase as much as tranquillizer therapy. No effect of any kind of therapy was found on the subjective complaints. A remarkable dissociation was found between the measured ventilatory parameters and the quantified subjective complaints. It is concluded that beta-blockade is an effective therapy for the basic problem of hypocapnia in the hyperventilation syndrome; in this respect it is to be preferred over other therapies such as tranquillizers.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6828803     DOI: 10.1159/000194523

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  2 in total

1.  Neurological manifestations of the hyperventilation syndrome.

Authors:  G D Perkin; R Joseph
Journal:  J R Soc Med       Date:  1986-08       Impact factor: 5.344

Review 2.  Hyperventilation syndrome.

Authors:  R E Brashear
Journal:  Lung       Date:  1983       Impact factor: 2.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.